The problem of non-superiority: what do we know after KOMET?
- PMID: 23123641
- DOI: 10.1136/jnnp-2012-303744
The problem of non-superiority: what do we know after KOMET?
Keywords: EPILEPSY; EVIDENCE-BASED NEUROLOGY; RANDOMISED TRIALS.
Comment on
-
KOMET: an unblinded, randomised, two parallel-group, stratified trial comparing the effectiveness of levetiracetam with controlled-release carbamazepine and extended-release sodium valproate as monotherapy in patients with newly diagnosed epilepsy.J Neurol Neurosurg Psychiatry. 2013 Oct;84(10):1138-47. doi: 10.1136/jnnp-2011-300376. Epub 2012 Aug 29. J Neurol Neurosurg Psychiatry. 2013. PMID: 22933814 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources